The global tympanostomy products market, valued at US$ 103.6 Mn in 2022, is projected to reach US$ 139.7 Mn by 2031, driven by the rising prevalence of ear infections, increasing adoption of tympanostomy products, and technological advancements. Key players include Olympus Corporation, Medtronic plc, and Atos Medical.
The global pseudarthrosis treatment market is projected to reach US$ 1.37 billion by 2034, driven by rising research and development, advancements in biocompatible materials, and positive government reimbursement programs. North America holds the largest market share, while demand is growing rapidly in South Asia & Pacific.
BioCardia Inc (BCDA) shares skyrocketed on Thursday after receiving FDA clearance for its Morph DNA Steerable Introducer product family, designed to facilitate medical instrument insertion during cardiovascular procedures. The company expects this new product line to enhance outcomes for a variety of interventional procedures.
Medtronic, a leading medical device company, is set to report its first-quarter fiscal 2025 earnings on August 20th. While the company faces challenges from rising costs and currency fluctuations, its underlying business remains strong with several growth drivers. This report examines the key factors that will likely influence Medtronic’s Q1 performance.
The global Healthcare Distribution Market is projected to grow significantly, driven by factors like the increasing demand for medical devices, the rise of chronic diseases, and the growing elderly population. Advanced technologies like IoT and AI are transforming supply chain operations, leading to better efficiency and insights. Key players in the market are focusing on strategic partnerships and acquisitions to expand their reach and product offerings.
Medtronic, a leading medical device manufacturer, exceeded first-quarter 2025 earnings expectations, driven by strong performance across multiple franchises. The company also raised its full-year guidance, citing continued growth from new product launches and investments.
The global brachytherapy devices market, valued at US$ 1.0 Bn in 2023, is projected to reach US$ 1.9 Bn by 2034, growing at a CAGR of 5.9%. This growth is driven by increasing cancer prevalence, technological advancements in brachytherapy, and rising awareness of its benefits.
The global wound healing film market is expected to experience significant growth in the coming years, driven by factors such as advancements in film technology, increasing prevalence of chronic diseases, and rising demand for home-based healthcare. The market is projected to reach US$ 1.18 billion by 2034, with hospitals representing a significant share of the revenue.
A new study comparing the environmental footprint of an innovative prefilled injection device to traditional glass syringes reveals a significant reduction in greenhouse gas emissions and resource consumption. The study, conducted by researchers at The Brookings Institution and Yale School of Public Health, found that the ApiJect Prefilled Injector reduces emissions by up to 125% compared to single-dose glass vials and significantly outperforms other injection device options.
In a bid to ensure the quality and safety of medical devices and IVDs, the Drugs Controller General of India (DCGI) has mandated compliance with Bureau of Indian Standards (BIS) for product testing. This move aims to address concerns about the use of untested or substandard medical devices, which pose health risks. Despite the directive, challenges remain due to the limited availability of BIS standards for the wide range of devices used in India. However, the Ministry of Health has authorized the use of Medical Device Rules (MDR) standards when BIS standards are unavailable.
